DFIR.SI
DFIR.SI has a high debt-to-equity ratio of 8.52, indicating a capital structure heavily reliant on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 0.41, suggesting limited short-term liquidity to cover immediate liabilities. The company's free cash flow of 190.4 million USD is positive, but its operating cash flow of 1.099 billion USD is partially offset by capital expenditures of 148.8 million USD. In terms of profitability, DFIR.SI's return on equity of 84.39% is significantly higher than the typical industry benchmark, indicating strong returns for shareholders. However, its return on assets of 5.05% is relatively modest, suggesting that the company is not efficiently utilizing its assets to generate returns. The company's gross profit of 3.255 billion USD and operating income of 329.5 million USD reflect a healthy margin structure, but the net income of 234.7 million USD is lower than the gross profit, indicating significant operating expenses. DFIR.SI's revenue is concentrated in the Food & Drug Retailing segment, with no disclosed geographic diversification. The company's total revenue of 8.869 billion USD is derived from a single business line, which may expose it to higher operational and market risks. The lack of geographic diversification could limit the company's ability to mitigate regional economic downturns or supply chain disruptions. Looking ahead, DFIR.SI is expected to maintain a stable revenue trajectory, with no significant growth or decline projected in the current or next fiscal year. The company's capital expenditures are expected to remain consistent, supporting ongoing operations rather than expansion. The company's free cash flow is expected to remain positive, but the high debt load may constrain future investment opportunities. The company's risk profile is characterized by medium liquidity risk and low dilution potential. The key risk flag is the negative net cash position after subtracting total debt, which could impact the company's ability to meet long-term obligations. The company's debt-to-equity ratio of 8.52 is significantly higher than the industry median, indicating a higher financial leverage risk. The company has not issued additional shares recently, and there is no indication of near-term dilution pressure. Recent events and filings indicate that DFIR.SI has maintained a stable financial position, with no major disruptions or regulatory issues reported. The company's analyst estimates suggest a mean price target of 5.11 USD, with a median of 5.03 USD, indicating a generally positive outlook from the investment community. The mean recommendation of 1.89 suggests a slight bias toward buy ratings, with 2 strong-buy and 6 buy recommendations.
Business. DFIR.SI operates in the Food Retail & Distribution industry, generating revenue primarily through the sale of food and drug products to consumers.
Classification. DFIR.SI is classified under the industry Food Retail & Distribution within the Consumer Non-Cyclicals economic sector, with a confidence level of 0.92.
- DFIR.SI has a high debt-to-equity ratio of 8.52, indicating a capital structure heavily reliant on debt financing.
- The company's return on equity of 84.39% is significantly higher than the typical industry benchmark, indicating strong returns for shareholders.
- DFIR.SI's revenue is concentrated in the Food & Drug Retailing segment, with no disclosed geographic diversification.
- The company's risk profile is characterized by medium liquidity risk and low dilution potential.
- Analyst estimates suggest a generally positive outlook, with a mean price target of 5.11 USD and a mean recommendation of 1.89.
- # RATIONALES
- {
- "margin_outlook_rationale": "DFIR.SI's gross profit margin is expected to remain stable, supported by consistent pricing and cost management strategies.",
- Net cash is negative after subtracting total debt.